Radiological response in saudi patients undergoing transarterial chemoembolization for hepatocellular carcinoma

Saudi Journal of Gastroenterology

Volumn 13, Issue 1, 2007, Pages 21-24

  Al Fuhaid, Turki ^b   Al Madi, Majid ^a   Al Abdul Kareem, Huda ^b   Al Dukhayil, Manal ^b   Abdo, Ayman A ^b,c  

^a MCGILL UNIVERSITY   (Canada)

^b KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^c Sheikh Bahamdan Research Chair of Evidence based Healthcare and Knowledge Translation   (Saudi Arabia)

Author keywords

Hepatocellular carcinoma; Transarterial chemoembolization

Indexed keywords

EID: 34247531957     PISSN: 13193767     EISSN: None     Source Type: Journal    
DOI: 10.4103/1319-3767.30461     Document Type: Article

References (12)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999;13:271-85.
2. Kingdom of Saudi Arabia ministry of health. National Cancer Registry (1997-1998). 2001.
3. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-30.
4. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918-28.
5. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998;28:751-5.
6. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomized controlled trial. Lancet 2002;359:1734-9.
7. Miller AB, Hoogstraten B, Straaquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
8. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
9. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of Transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-71.
10. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003;37:429-42.
11. Breedis C, Young C. The blood supply of neoplasm in liver. Am J Pathol 1954;30:969-77.
12. Abdo AA, Karim HA, Al Fuhaid T, Sanai FM, Kabbani M, Al Jumah A, et al, Saudi Gastroenterology Association Guidelines for the diagnosis and management of hepatocellular carcinoma: Summary of recommendations. Ann Saudi Med 2006;26:261-5.